Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immatics NV (IMTX)

Immatics NV (IMTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immatics NV PAUL EHRLICH-STRASSE 15 TUBINGEN 2M 72076 DEU

www.immatics.com Employees: 423 P: 071-539-7700 F: 071-539-7900

Sector:

Medical

Description:

Immatics N.V. engages in the discovery of targets for cancer immunotherapies. It is developing targeted immunotherapies with focus on treating solid tumors. Immatics N.V., formerly known as ARYA SCIENCES, is based in Tuebingen, Germany.

Key Statistics

Overview:

Market Capitalization, $K 1,215,500
Enterprise Value, $K 824,130
Shares Outstanding, K 121,550
Float, K 121,550
% Float 100.00%
Short Interest, K 5,463
Short Float 4.49%
Days to Cover 13.37
Short Volume Ratio 0.26
% of Institutional Shareholders 64.41%

Financials:

Annual Sales, $ 54,610 K
Annual Net Income, $ -222,260 K
Last Quarter Sales, $ 23,590 K
Last Quarter Net Income, $ -41,330 K
EBIT, $ -205,940 K
EBITDA, $ -191,910 K

Growth:

1-Year Return 114.59%
3-Year Return 31.58%
5-Year Return -29.53%
5-Year Revenue Growth 74.75%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.49 on 11/17/25
Next Earnings Date 05/12/26
Earnings Per Share ttm -1.84
EPS Growth vs. Prev Qtr 30.61%
EPS Growth vs. Prev Year -170.83%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IMTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -41.81%
Return-on-Assets % -34.72%
Profit Margin % 9.77%
Debt/Equity 0.00
Price/Sales 21.95
Price/Cash Flow 41.54
Price/Book 2.53
Book Value/Share 4.51
Interest Coverage -4.41
60-Month Beta 1.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar